FDA provides clearance of TyRx antibacterial patch for soft tissue repair

News | 04. 27. 2010

TYRX

TYRX, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market AIGISRx® ST , its antibacterial product for the surgical repair of damaged or ruptured soft tissue.